Locad secures USD 9 mn in pre-series B funding
The funding will be used for expansion purposes
Available in your choice of English or Arabic
The funding will be used for expansion purposes
This funding round increases the company’s total funding to USD 31 mn
The funds will be used for expansion purposes
CrossBridge Bio will use the proceeds to advance its flagship cancer treatment
NorthLadder will use the funding to expand in new international markets
The company expects to achieve profitability by the close of FY 2024
The funding round was led by Shorooq Partners
PiP World will use the funding to expand into emerging markets
Something went wrong. Please refresh the page and/or try again.
Queue